Service Hotline +86 400-068-7188
Service Hotline +86 400-068-7188
China Pharmaceutical Business Market Forecast and Investment Strategic Planning Report, 2013-2017
A must-have for enterprise medium to long-term strategic planning
Without deep industry knowledge, it will be difficult to gain any return
English Version：USD7900
Including: Paper back + Electronic Copy + Invoice
Customer Hotline：+86 755 - 82925195 / 82925295
Free Hotline：+86 400-068-7188After-sales Hotline： +86 755-33013088
The Ministry of Commerce of the People's Republic of China designated Qianzhan Industrial Research Institute as the only "regional workstation for dealing with trade friction" in the Guangdong-Hong Kong-Macao Greater Bay Area
Customer Hotline：+86 755 - 82925195 / 82925295
Free Hotline：+86 400-068-7188
0755 - 82925195
400-068-7188
We are aware of that the content of our products have been stolen by some ones who changed the design and used it to deceive customers as it is their own products. Customers who are misled may experience no product received or an incomplete product.
Therefore, Qianzhan Industrial Research Institute encourage you to arrange an in-person visit to our company before you make the purchase.
Qianzhan has the sole copyright of all research reports. We have never had partnership or affiliated with any third party agent. Please recognize the"
"trademark when purchasing reports.To have better investment return or strategic outcomes, you must have a forward-looking vision. Qianzhan Industrial Research Institute - China's leading industry consulting institutions provide you with all the things you need in business!
* The table of contents and the rest of this report are originally created by Qianzhan. Without any prior written permission, it is prohibited to copy or reproduce in any way. To have better investment return or strategic outcomes, you must have a forward-looking vision!
Table of Contents
Content Summary
Chapter 1: Development Backgroud Analysis of Pharmaceutical Business
1.1 Definition and Classification of Pharmaceutical Business
1.1.1 Definition of Pharmaceutical Business
1.1.2 Operational Features of Pharmaceutical Business
1.1.3 Enterprise Classification of Pharmaceutical Business
(1) Classification by Operational License
(2) Classification by Pharmaceutical Wholesales Enterprises’ Operational Modes
(3) Classification by Size of Operational Regions
(4) Classification by Sales Volume
(5) Classification by Sales Objects
(6) Classification by Drugs
1) Classification by Public Welfare Property of Drugs
2) Classification by Specialty of Drugs
3) Classification by Safety Property and Prescription Management System
(7) Classification by Transaction Means
(8) Classification by Logistics Standards
1.2 Entry Barriers Analysis of Pharmaceutical Commercial Business
1.2.1 Professional Certification Barriers
(1) GSP Certification Standards
(2) New Standards for Drugstore Changing License
(3) Standards for Newly Open Drugstore Applying for License
(4) Standards for Applying for Medical Device Operational License
(5) Standards for Drug Modern Logistics Enterprises
1.2.2 Operational Qualification Barriers
(1) Operational Qualification for Toxic and Anesthetic Drug
(2) Operational Qualification for Anabolic Agents
(3) Operational Qualification for Emedchina
(4) Operational Qualification for Cold Chain Management
(5) Barrier to Informalization Construction
1.2.3 Barrier to Enterprise Size
1.2.4 Barrier to Brand Credit
1.2.5 Barrier to Capital Strengths
1.2.6 Barrier to Marketilization
(1) Terminal Entry Barrier of Hospitals above Designated Size
(2) Authorization Receiving of Pharmaceutical Industrial Channels
1.2.7 Policy Barrier
1.3 Analysis of Policy Environment of Pharmaceutical Business
1.3.1 Supervision Departments of Pharmaceutical Business
(1) State Food and Drug Administration (SFDA)
(2) China Association of Pharmaceutical Commerce (CAPC)
1.3.2 Management System of Pharmaceutical Business
(1) System of Pharmaceutical Operational License
(2) Quality Management Rules to Pharmaceutical Operational Quality
(3) Drugs Biding Invitation, Procurement and Delivery Management
(4) Management System of Drug Price
(5) Classification System of Prescription Medicine and OTC
1.3.3 Laws and Regulations Related to Pharmaceutical Business
(1) The Drug Administration Law of the People's Republic of China
(2) Quality Management in the Drug Industry
(3) Supervision and Administration of Circulation of Pharmaceuticals
(4) Drug Business License Management Measures
(5) Medical Device Distribution Enterprise License Management Measures
(6) The Narcotic Drugs and Psychotropic Substances (NDPS) Act
1.3.4 Policies Related to Pharmaceutical Business
(1) “Eleventh Five-year” Development Guidance Opinion on Pharmaceutical Industry
(2) Opinions on Deepening the Reform of the Medical and Health Care System
1) Government’s Increasing Investment Results in Fast Growing of Pharmaceutical Market
2) Medical Reform Keeps Requiring Higher Industry Entry Threshold
3) Government Runs Medical Institutions to Standardize Bidding Invitation and Procurement
4) Medical Reform Requires to Develop Modern Logistics
5) Medical Reform Standardize Capital Settlement of Pharmaceutical Business in Medical Institutions
6) Medical Reform Requires to Reduce Drug Circulation Links
7) Medical Reform Promotes Construction of Basic Drug System
(3) Plan for the Recent Priorities of the Health Care System Reform (2009–2011)
(4) Implementing Opinions on Establishing the National Essential Drug System
1.3.5 Development Plan Outline on National Medical Circulation Industry
1.4 Analysis of Pharmaceutical Demand Environment
1.4.1 Analysis of Residential Payment Ability
(1) Resident Per Capital GDP
(2) Resident Income Level
(3) Resident Medical Healthcare Level
1.4.2 Population Size and Aging
(1) Population Volume
(2) Changes of Population Structure
1.4.3 Resident Morbidity
1.5 Industry Research Methods and Data Source
1.5.1 Industry Research Methods
1.5.2 Industry Data Source
Chapter 2: Development Status and Prospects Analysis of Pharmaceutical Business
2.1 Medicine Supply Chain Status and Management Mode
2.1.1 Definition of Drug Supply Chain
(1) Specialty of Drugs
(2) Definition of Drug Supply Chain
2.1.2 Analysis of Drug Supply Chain Constitution
(1) Organizational Nodes
(2) Organizational Constraints
2.1.3 Development Status of Drug Supply Chain
(1) Drug Production
(2) Drug Circulation
(3) Drug Consumption
2.1.4 Management Mode of Drug Supply Chain
(1) Hospital-oriented Drug Supply Chain Management Mode
(2) Supplier-oriented Drug Supply Chain Management Mode
(3) Third-party Drug Circulation-oriented Drug Supply Chain Management Mode
(4) Comparison Analysis of Three Kinds of Drug Supply Chain Management Modes
2.2 Operational Mode and Marketing Strategy of Pharmaceutical Business
2.2.1 Operational Mode Analysis of Pharmaceutical Business
(1) Direct Selling Mode
(2) Allocation Business Mode
(3) Fast Wholesale Business Mode
(4) Agent Business Mode
(5) Third-party Logistics Business Mode
2.2.2 Analysis of Pharmaceutical Business Channel Modes
(1) Three-station Mode
(2) Total Distribution Mode
(3) Regional Distribution Mode
(4) Diversified Agents System in A Region Mode
(5) Terminal Mode
2.2.3 Marketing Channel Modes Selection of Pharmaceutical Enterprises
(1) Influencing Factors to Marketing Channel Modes
(2) Enterprise Sales Team + Distributors Mode
(3) Exclusive Agent Channel Mode
(4) Diversified Agents Channel Mode
2.2.4 Enterprises’ Marketing Strategies under New Medical Reform
(1) Adjusting Product Target Market
(2) Adjusting Marketing Ideology
(3) Accelerate to Adjust Drug Price System
2.3 Development Size of Pharmaceutical Business
2.3.1 Analysis of Pharmaceutical Business’s Development Size and Profit
(1) Enterprise Quantity Volume
(2) Enterprise Regional Distribution
2.3.2 Market Size of Pharmaceutical Business
(1) Total Market Sales Volume
(2) Regional Sales Distribution
2.3.3 Analysis of Pharmaceutical Business’s Profit
(1) Analysis of Pharmaceutical Business’s Profit Factors
(2) Traditional Profit Mode of Pharmaceutical Business
(3) Emerging Profit Mode of Pharmaceutical Business
(4) Profit Level Changes of Pharmaceutical Business
2.4 Analysis of Product Market Volume of Pharmaceutical Business
2.4.1 General Information of Seven Kinds of Commercial Product Markets
2.4.2 Analysis of Seven Kinds of Major Commercial Product Markets
(1) Analysis of Drug Market
(2) Analysis of Chinese Patent Medicine Market
(3) Analysis of Chinese Herbal Medicine Market
(4) Analysis of Medical Device Market
(5) Analysis of Chemical Agent Market
(6) Analysis of Glass Device Market
2.4.3 Analysis of First-level Distribution Market for Special Drugs
2.5 Development Analysis of Pharmaceutical Business Informalization
2.5.1 Necessity of Constructing Pharmaceutical Business Informalization
2.5.2 Importance to Construct Pharmaceutical Business Informalization
2.5.3 Informalization Status of Field Segmentation of Pharmaceutical Business
(1) Pharmaceutical Wholesale Informalization Status
(2) Pharmaceutical Logistic Informalization Status
(3) Pharmaceutical Retail Informalization Status
2.5.4 Problems in Pharmaceutical Business Informalization
2.5.5 Development Strategies for Pharmaceutical Business Informalization
2.6 Development Prospects Forecast for Pharmaceutical Business
2.6.1 Development Driving Factors to Pharmaceutical Business
(1) Strong Terminal Demand for Drugs
(2) Rising of Primary-level Medical Market
(3) Gradually Improved Industry Entry Threshold
(4) Policy Orientation of National Industry Concentration
(5) Industry Management Tending to Be Standardized
(6) Implementation of Basic Drug System
(7) Unifying Provincial Bidding Invitation
(8) Clear Industry Management Department
2.6.2 Development Restraining Factors to Pharmaceutical Business
(1) Not High Industry Concentration
(2) Lack of Pharmaceutical Talents
(3) Low Degree of Pharmaceutical Business Informalization
(4) Low Logistic Distribution Level of Pharmaceutical Business
2.6.3 Analysis of Development Routines of Pharmaceutical Business
(1) Internal Promotional Routines of Pharmaceutical Business
(2) External Expansion Routines of Pharmaceutical Business
2.6.4 Development Prospects Forecast for Pharmaceutical Business
Chapter 3: Competition and Restructuring/Integration of Pharmaceutical Business Enterprise
3.1 Analysis of Competitive Landscape of Pharmaceutical Business Enterprise
3.1.1 Sales Structure of Pharmaceutical Business Enterprise
3.1.2 Ranking Analysis of Pharmaceutical Business Enterprise
3.1.3 Concentration Analysis of Pharmaceutical Business Enterprise
3.2 Analysis of Restructuring and Integration of Pharmaceutical Business Enterprise
3.2.1 Promotional Factors to Restructuring and Integration of Pharmaceutical Business Enterprise
3.2.2 Analysis of Restructuring and Integration of Pharmaceutical Business Enterprise
(1) Analysis of Restructuring and Integration of Pharmaceutical Business State-owned Enterprise
(2) Analysis of Restructuring and Integration of Pharmaceutical Business Regional Enterprise
(3) Analysis of Restructuring and Integration of Pharmaceutical Business Private Enterprise
(4) Analysis of Coalition Restructuring and Integration of Pharmaceutical Business Enterprise
(5) Analysis of Restructuring and Integration of Pharmaceutical Business Foreign Enterprise
3.3 Analysis of Financing Strategies for Pharmaceutical Business Enterprise
3.3.1 Analysis of Financing Mode of Pharmaceutical Business Enterprise
(1) Division of Financing Methods
(2) Financing Mode Status
(3) Existing Problems and Causes
3.3.2 Financing Channels of Pharmaceutical Business Listed Enterprises
(1) Bank Loan
(2) Security Market Financing
(3) Financing of Other Non-bank Financial Institutions
3.3.3 Financing Strategies for Pharmaceutical Business Listed Enterprises
(1) Basic Principles of Financing Strategies
(2) Operation of Different Financing Methods
(3) Financing Strategies Selection
3.3.4 Financing Cases of Pharmaceutical Business Listed Enterprises
(1) NanJing Pharmaceutical Company Limited
(2) Zhejiang Medicine Company Limited
(3) Positive Roles of Successful Modes
3.3.5 Financing Strategy Suggestions for Pharmaceutical Business Enterprises
3.4 Competition Rival Analysis of Pharmaceutical Business Enterprises
3.4.1 Operation Analysis of Sinopharm Group Co., Ltd.
(1) Brief Analysis of Enterprise Development
(2) Enterprise Main Business and Products
(3) Enterprise Main Clients and Suppliers
(4) Analysis of Enterprise Operational Situation
1) Analysis of Major Economic Indexes
2) Analysis of Enterprise Profitability
3) Analysis of Enterprise Operational Capability
4) Analysis of Enterprise Debt-paying Capability
5) Analysis of Enterprise Development Capability
(5) SWOT Analysis of Enterprise Operation
(6) Analysis of Enterprise Logistics System Construction
(7) Analysis of Enterprise Investment Development Trend
(8) Analysis of Affiliated Companies of Sinopharm Group Co., Ltd.
1) Development Brief of Enterprise
2) Enterprise Retail Product Category
3) Analysis of Enterprise Retail Volume
4) Enterprise Retail Network Distribution
3.4.2 Operation Analysis of China National Accord Medicines Co., Ltd.
(1) Brief Analysis of Enterprise Development
(2) Enterprise Main Business and Products
(3) Enterprise Main Clients and Suppliers
(4) Analysis of Enterprise Operational Situation
1) Analysis of Major Economic Indexes
2) Analysis of Enterprise Profitability
3) Analysis of Enterprise Operational Capability
4) Analysis of Enterprise Debt-paying Capability
5) Analysis of Enterprise Development Capability
(5) SWOT Analysis of Enterprise Operation
(6) Analysis of Enterprise Logistics System Construction
(7) Analysis of Enterprise Development Strategy Planning
(8) Analysis of Enterprise Latest Development Trend
3.4.3 Operation Analysis of China National Health Pharmaceutical (Group) Co., Ltd.
(1) Brief Analysis of Enterprise Development
(2) Enterprise Main Business and Products
(3) Enterprise Main Clients and Suppliers
(4) Analysis of Enterprise Operational Situation
1) Analysis of Major Economic Indexes
2) Analysis of Enterprise Profitability
3) Analysis of Enterprise Operational Capability
4) Analysis of Enterprise Debt-paying Capability
5) Analysis of Enterprise Development Capability
(5) SWOT Analysis of Enterprise Operation
(6) Analysis of Enterprise Logistics System Construction
(7) Analysis of Enterprise Development Strategy Planning
(8) Analysis of Enterprise Latest Development Trend
3.4.4 Operation Analysis of Shanghai Pharmaceutical (Group) Co., Ltd.
(1) Brief Analysis of Enterprise Development
(2) Enterprise Main Business and Products
(3) Enterprise Main Clients and Suppliers
(4) Analysis of Enterprise Operational Situation
1) Analysis of Major Economic Indexes
2) Analysis of Enterprise Profitability
3) Analysis of Enterprise Operational Capability
4) Analysis of Enterprise Debt-paying Capability
5) Analysis of Enterprise Development Capability
(5) SWOT Analysis of Enterprise Operation
(6) Analysis of Enterprise Logistics System Construction
(7) Analysis of Enterprise Development Strategy Planning
(8) Analysis of Enterprise Latest Development Trend
(9) Analysis of Affiliated Companies of Shanghai Huash Pharmaceutical Co., Ltd.
1) Development Brief of Enterprise
2) Enterprise Retail Product Category
3) Analysis of Enterprise Retail Volume
3.4.5 Operation Analysis of Nanjing Pharmaceutical Co., Ltd.
(1) Brief Analysis of Enterprise Development
(2) Analysis of Enterprise Organization Structure
(3) Enterprise Main Clients and Suppliers
(4) Analysis of Enterprise Operational Situation
1) Analysis of Major Economic Indexes
2) Analysis of Enterprise Profitability
3) Analysis of Enterprise Operational Capability
4) Analysis of Enterprise Debt-paying Capability
5) Analysis of Enterprise Development Capability
(5) SWOT Analysis of Enterprise Operation
(6) Analysis of Enterprise Logistics System Construction
(7) Analysis of Enterprise Development Strategy Planning
(8) Analysis of Enterprise Latest Development Trend
(9) Analysis of Affiliated Companies of Nanjing Pharmaceutical Co., Ltd.
1) Development Brief of Enterprise
2) Enterprise Retail Product Category
3) Analysis of Enterprise Retail Volume
4) Enterprise Retail Network Distribution
3.4.6 Operation Analysis of Guangzhou Pharmaceutical Co., Ltd.
(1) Brief Analysis of Enterprise Development
(2) Analysis of Enterprise Organization Structure
(3) Enterprise Main Clients and Suppliers
(4) Analysis of Enterprise Operational Situation
1) Analysis of Major Economic Indexes
2) Analysis of Enterprise Profitability
3) Analysis of Enterprise Operational Capability
4) Analysis of Enterprise Debt-paying Capability
5) Analysis of Enterprise Development Capability
(5) SWOT Analysis of Enterprise Operation
(6) Analysis of Enterprise Logistics System Construction
(7) Analysis of Enterprise Investment Development Trend
(8) Analysis of Affiliated Companies of Guangzhou Jianmin Pharmaceutical Chain Stores Co., Ltd.
1) Development Brief of Enterprise
2) Enterprise Retail Product Category
3) Enterprise Retail Network Distribution
3.4.7 Operation Analysis of Anhui Huayuan Pharmaceutical Co., Ltd.
(1) Brief Analysis of Enterprise Development
(2) Analysis of Enterprise Organization Structure
(3) Enterprise Main Business and Products
(4) Analysis of Enterprise Main Clients and Suppliers
(5) Analysis of Enterprise Operational Situation
(6) Analysis of Enterprise Logistics System Construction
(7) Analysis of Enterprise Development Strategy Planning
(8) Analysis of Enterprise Latest Development Trend
(9) Analysis of Affiliated Companies of E-commerce of Anhui Huayuan Pharmaceutical Co., Ltd.
1) Development Brief of Enterprise
2) Enterprise Retail Product Category
3) Enterprise Retail Network Distribution
3.4.8 Operation Analysis of Beijing Pharmaceutical Co., Ltd.
(1) Brief Analysis of Enterprise Development
(2) Analysis of Enterprise Organization Structure
(3) Enterprise Main Business and Products
(4) Analysis of Enterprise Main Clients and Suppliers
(5) Analysis of Enterprise Operational Situation
(6) Analysis of Enterprise Logistics System Construction
(7) Analysis of Enterprise Development Strategy Planning
(8) Analysis of Enterprise Investment Development Trend
(9) Analysis of Affiliated Companies of Beijing Healthcare New Drugstore Co., Ltd.
1) Development Brief of Enterprise
2) Enterprise Retail Product Category
3) Analysis of Enterprise Retail Volume
4) Enterprise Retail Network Distribution
3.4.9 Operation Analysis of Jointown Pharmaceutical Group Co., Ltd.
(1) Brief Analysis of Enterprise Development
(2) Analysis of Enterprise Organization Structure
(3) Enterprise Main Clients and Suppliers
(4) Analysis of Enterprise Operational Situation
1) Analysis of Major Economic Indexes
2) Analysis of Enterprise Profitability
3) Analysis of Enterprise Operational Capability
4) Analysis of Enterprise Debt-paying Capability
5) Analysis of Enterprise Development Capability
(5) SWOT Analysis of Enterprise Operation
(6) Analysis of Enterprise Logistics System Construction
(7) Analysis of Enterprise Investment Development Trend
(8) Analysis of Affiliated Companies of Beijing Haoyaoshi Pharmacy Chain Company
1) Development Brief of Enterprise
2) Enterprise Retail Product Category
3) Enterprise Retail Network Distribution
3.4.10 Operation Analysis of Tianjin Pharmaceutical Holdings Ltd.
(1) Brief Analysis of Enterprise Development
(2) Analysis of Enterprise Organization Structure
(3) Enterprise Main Business and Products
(4) Analysis of Enterprise Main Clients and Suppliers
(5) Analysis of Enterprise Operational Situation
(6) SWOT Analysis of Enterprise Operation
(7) Analysis of Enterprise Development Strategy Planning
(8) Analysis of Affiliated Companies of Tianjin Jinyitang Investment Group Co., Ltd.
1) Development Brief of Enterprise
2) Enterprise Retail Product Category
3) Analysis of Enterprise Retail Volume
4) Enterprise Retail Network Distribution
3.4.11 Operation Analysis of Sichuan Kelun Pharmaceutical Co., Ltd.
(1) Brief Analysis of Enterprise Development
(2) Enterprise Main Business and Products
(3) Enterprise Main Clients and Suppliers
(4) Analysis of Enterprise Operational Situation
(5) SWOT Analysis of Enterprise Operation
(6) Analysis of Enterprise Logistics System Construction
3.4.12 Operation Analysis of Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
(1) Brief Analysis of Enterprise Development
(2) Analysis of Enterprise Organization Structure
(3) Enterprise Main Business and Products
(4) Analysis of Enterprise Operational Situation
1) Analysis of Major Economic Indexes
2) Analysis of Enterprise Profitability
3) Analysis of Enterprise Operational Capability
4) Analysis of Enterprise Debt-paying Capability
5) Analysis of Enterprise Development Capability
(5) SWOT Analysis of Enterprise Operation
(6) Analysis of Enterprise Logistics System Construction
(7) Analysis of Enterprise Development Strategy Planning
(8) Analysis of Enterprise Investment Development Trend
(9) Analysis of Affiliated Companies of Hangzhou Huadong Grand Pharmacy Chain, Ltd.
1) Development Brief of Enterprise
2) Enterprise Retail Product Category
3) Analysis of Enterprise Retail Volume
4) Enterprise Retail Network Distribution
3.4.13 Operation Analysis of Zhejiang Int'l Group Co., Ltd.
(1) Brief Analysis of Enterprise Development
(2) Enterprise Main Business and Products
(3) Enterprise Main Clients and Suppliers
(4) Analysis of Enterprise Operational Situation
1) Analysis of Major Economic Indexes
2) Analysis of Enterprise Profitability
3) Analysis of Enterprise Operational Capability
4) Analysis of Enterprise Debt-paying Capability
5) Analysis of Enterprise Development Capability
(5) SWOT Analysis of Enterprise Operation
(6) Analysis of Enterprise Logistics System Construction
(7) Analysis of Enterprise Development Strategy Planning
(8) Analysis of Enterprise Investment Development Trend
3.4.14 Operation Analysis of Harbin Pharmaceutical Group Holding Co., Ltd.
(1) Brief Analysis of Enterprise Development
(2) Analysis of Enterprise Organization Structure
(3) Enterprise Main Business and Products
(4) Analysis of Main Clients and Suppliers
(5) Analysis of Enterprise Operational Situation
1) Analysis of Major Economic Indexes
2) Analysis of Enterprise Profitability
3) Analysis of Enterprise Operational Capability
4) Analysis of Enterprise Debt-paying Capability
5) Analysis of Enterprise Development Capability
(6) SWOT Analysis of Enterprise Operation
(7) Analysis of Enterprise Logistics System Construction
(8) Analysis of Enterprise Investment Development Trend
(9) Analysis of Affiliated Companies of Harbin Pharmaceutical Group Holding Co., Ltd.
1) Development Brief of Enterprise
2) Enterprise Retail Product Category
3) Analysis of Enterprise Retail Volume
4) Enterprise Retail Network Distribution
3.4.15 Operation Analysis of China Pharmaceutical Healthcare Products Co., Ltd.
(1) Brief Analysis of Enterprise Development
(2) Analysis of Enterprise Organization Structure
(3) Enterprise Main Business and Products
(4) Analysis of Main Clients and Suppliers
(5) Analysis of Enterprise Operational Situation
1) Analysis of Major Economic Indexes
2) Analysis of Enterprise Profitability
3) Analysis of Enterprise Operational Capability
4) Analysis of Enterprise Debt-paying Capability
5) Analysis of Enterprise Development Capability
(6) SWOT Analysis of Enterprise Operation
(7) Analysis of Enterprise Logistics System Construction
(8) Analysis of Enterprise Investment Development Trend
3.4.16 Operation Analysis of Lerentang Pharmaceutical Group Co., Ltd.
(1) Brief Analysis of Enterprise Development
(2) Analysis of Enterprise Organization Structure
(3) Enterprise Main Business and Products
(4) Analysis of Main Clients and Suppliers
(5) Analysis of Enterprise Operational Situation
(6) SWOT Analysis of Enterprise Operation
(7) Analysis of Enterprise Logistics System Construction
(8) Analysis of Enterprise Investment Development Trend
(9) Analysis of Affiliated Companies of ShijiaZhuang Lerentang Pharmaceutical Group Co., Ltd.
1) Development Brief of Enterprise
2) Enterprise Retail Product Category
3) Analysis of Enterprise Retail Volume
4) Enterprise Retail Network Distribution
3.4.17 Operation Analysis of Yunnan Baiyao Group Co., Ltd.
(1) Brief Analysis of Enterprise Development
(2) Analysis of Enterprise Organization Structure
(3) Enterprise Main Business and Products
(4) Analysis of Main Clients and Suppliers
(5) Analysis of Enterprise Operational Situation
1) Analysis of Major Economic Indexes
2) Analysis of Enterprise Profitability
3) Analysis of Enterprise Operational Capability
4) Analysis of Enterprise Debt-paying Capability
5) Analysis of Enterprise Development Capability
(6) SWOT Analysis of Enterprise Operation
(7) Analysis of Enterprise Logistics System Construction
(8) Analysis of Enterprise Investment Development Trend
(9) Analysis of Affiliated Companies of Yunnan Baiyao Group Co., Ltd.
1) Development Brief of Enterprise
2) Enterprise Retail Product Category
3) Analysis of Enterprise Retail Volume
4) Enterprise Retail Network Distribution
3.4.18 Operation Analysis of Joincare Pharmaceutical Industry Group Co., Ltd.
(1) Brief Analysis of Enterprise Development
(2) Analysis of Enterprise Organization Structure
(3) Enterprise Main Business and Products
(4) Analysis of Main Clients and Suppliers
(5) Analysis of Enterprise Operational Situation
1) Analysis of Major Economic Indexes
2) Analysis of Enterprise Profitability
3) Analysis of Enterprise Operational Capability
4) Analysis of Enterprise Debt-paying Capability
5) Analysis of Enterprise Development Capability
(6) SWOT Analysis of Enterprise Operation
(7) Analysis of Enterprise Investment Development Trend
3.4.19 Operation Analysis of Chongqing Tongjuge Pharmaceutical Factory Co., Ltd.
(1) Brief Analysis of Enterprise Development
(2) Analysis of Enterprise Organization Structure
(3) Enterprise Main Business and Products
(4) Analysis of Main Clients and Suppliers
(5) Analysis of Enterprise Operational Situation
1) Analysis of Major Economic Indexes
2) Analysis of Enterprise Profitability
3) Analysis of Enterprise Operational Capability
4) Analysis of Enterprise Debt-paying Capability
5) Analysis of Enterprise Development Capability
(6) SWOT Analysis of Enterprise Operation
(7) Analysis of Enterprise Logistics System Construction
(8) Analysis of Affiliated Companies of Chongqing Tongjunge Big Drugstore Chain Co., Ltd.
1) Development Brief of Enterprise
2) Enterprise Retail Product Category
3) Analysis of Enterprise Retail Volume
4) Enterprise Retail Network Distribution
3.4.20 Operation Analysis of Taiji Group Co., Ltd.
(1) Brief Analysis of Enterprise Development
(2) Analysis of Enterprise Organization Structure
(3) Enterprise Main Business and Products
(4) Analysis of Main Clients and Suppliers
(5) Analysis of Enterprise Operational Situation
1) Analysis of Major Economic Indexes
2) Analysis of Enterprise Profitability
3) Analysis of Enterprise Operational Capability
4) Analysis of Enterprise Debt-paying Capability
5) Analysis of Enterprise Development Capability
(6) SWOT Analysis of Enterprise Operation
(7) Analysis of Enterprise Logistics System Construction
(8) Analysis of Enterprise Investment Development Trend
3.4.21 Operation Analysis of Shandong Neptunus Galaxy Medicine Co., Ltd.
(1) Brief Analysis of Enterprise Development
(2) Enterprise Main Business and Products
(3) Enterprise Main Clients and Suppliers
(4) Analysis of Enterprise Operational Situation
(5) SWOT Analysis of Enterprise Operation
(6) Analysis of Enterprise Logistics System Construction
(7) Analysis of Enterprise Development Strategy Planning
(8) Analysis of Enterprise Latest Development Trend
3.4.22 Operation Analysis of Northeast Pharmaceutical Group Co., Ltd.
(1) Brief Analysis of Enterprise Development
(2) Analysis of Enterprise Organization Structure
(3) Enterprise Main Business and Products
(4) Analysis of Main Clients and Suppliers
(5) Analysis of Enterprise Operational Situation
1) Analysis of Major Economic Indexes
2) Analysis of Enterprise Profitability
3) Analysis of Enterprise Operational Capability
4) Analysis of Enterprise Debt-paying Capability
5) Analysis of Enterprise Development Capability
(6) SWOT Analysis of Enterprise Operation
(7) Analysis of Enterprise Logistics System Construction
(8) Analysis of Enterprise Investment Development Trend
(9) Analysis of Affiliated Companies of Northeast Pharmaceuticals Group Sales Co., Ltd.
1) Development Brief of Enterprise
2) Enterprise Retail Product Category
3) Analysis of Enterprise Retail Volume
4) Enterprise Retail Network Distribution
3.4.23 Operation Analysis of Hebei Dongsheng Yinghua Medicine Co., Ltd.
(1) Brief Analysis of Enterprise Development
(2) Enterprise Main Business and Products
(3) Enterprise Main Clients and Suppliers
(4) Analysis of Enterprise Operational Situation
(5) SWOT Analysis of Enterprise Operation
(6) Analysis of Enterprise Logistics System Construction
3.4.24 Operation Analysis of Tianjin Tasly Pharmaceutical Co., Ltd.
(1) Brief Analysis of Enterprise Development
(2) Analysis of Enterprise Organization Structure
(3) Enterprise Main Business and Products
(4) Analysis of Enterprise Operational Situation
1) Analysis of Major Economic Indexes
2) Analysis of Enterprise Profitability
3) Analysis of Enterprise Operational Capability
4) Analysis of Enterprise Debt-paying Capability
5) Analysis of Enterprise Development Capability
(5) SWOT Analysis of Enterprise Operation
(6) Analysis of Enterprise Logistics System Construction
(7) Analysis of Enterprise Development Strategy Planning
(8) Analysis of Enterprise Investment Development Trend
(9) Analysis of Affiliated Companies of Tianjin Tasly Medicine Distribution Group Co., Ltd.
1) Development Brief of Enterprise
2) Enterprise Retail Product Category
3) Analysis of Enterprise Retail Volume
4) Enterprise Retail Network Distribution
3.4.25 Operation Analysis of Beijing Tong Ren Tang Group Co., Ltd.
(1) Brief Analysis of Enterprise Development
(2) Analysis of Enterprise Organization Structure
(3) Enterprise Main Business and Products
(4) Analysis of Enterprise Operational Situation
1) Analysis of Major Economic Indexes
2) Analysis of Enterprise Profitability
3) Analysis of Enterprise Operational Capability
4) Analysis of Enterprise Debt-paying Capability
5) Analysis of Enterprise Development Capability
(5) SWOT Analysis of Enterprise Operation
(6) Analysis of Enterprise Logistics System Construction
(7) Analysis of Enterprise Investment Development Trend
(8) Analysis of Affiliated Companies of Drugstores of Beijing Tong Ren Tang Group Co., Ltd.
1) Development Brief of Enterprise
2) Enterprise Retail Product Category
3) Analysis of Enterprise Retail Volume
3.4.26 Operation Analysis of Shandong Realcan Pharmaceutical Co., Ltd.
(1) Brief Analysis of Enterprise Development
(2) Analysis of Enterprise Organization Structure
(3) Enterprise Main Business and Products
(4) Analysis of Enterprise Operational Situation
1) Analysis of Major Economic Indexes
2) Analysis of Enterprise Profitability
3) Analysis of Enterprise Operational Capability
4) Analysis of Enterprise Debt-paying Capability
5) Analysis of Enterprise Development Capability
(5) SWOT Analysis of Enterprise Operation
(6) Analysis of Enterprise Logistics System Construction
(7) Analysis of Enterprise Development Strategy Planning
3.4.27 Operation Analysis of Cachet Pharmaceutical Co., Ltd.
(1) Brief Analysis of Enterprise Development
(2) Analysis of Enterprise Organization Structure
(3) Enterprise Main Business and Products
(4) Analysis of Enterprise Operational Situation
1) Analysis of Major Economic Indexes
2) Analysis of Enterprise Profitability
3) Analysis of Enterprise Operational Capability
4) Analysis of Enterprise Debt-paying Capability
5) Analysis of Enterprise Development Capability
(5) SWOT Analysis of Enterprise Operation
(6) Analysis of Enterprise Logistics System Construction
(7) Analysis of Enterprise Development Strategy Planning
(8) Analysis of Enterprise Investment Development Trend
3.4.28 Operation Analysis of China Nepstar Chain Drugstore Ltd.
(1) Brief Analysis of Enterprise Development
(2) Enterprise Main Business and Products
(3) Enterprise Main Business and Products
(4) Analysis of Enterprise Operational Situation
1) Analysis of Major Economic Indexes
2) Analysis of Enterprise Profitability
3) Analysis of Enterprise Operational Capability
4) Analysis of Enterprise Debt-paying Capability
5) Analysis of Enterprise Development Capability
(5) SWOT Analysis of Enterprise Operation
(6) Analysis of Enterprise Latest Development Trend
3.4.29 Operation Analysis of LBX Pharmacy Co., Ltd.
(1) Brief Analysis of Enterprise Development
(2) Analysis of Enterprise Organization Structure
(3) Enterprise Main Business and Products
(4) Enterprise Retail Networks and Suppliers
(5) Analysis of Enterprise Operational Situation
(6) Analysis of Enterprise Advantages and Disadvantages
(7) Analysis of Enterprise Investment Development Trend
3.4.30 Operation Analysis of Guangdong Dasenlin Chain Drugstore Co., Ltd.
(1) Brief Analysis of Enterprise Development
(2) Analysis of Enterprise Organization Structure
(3) Enterprise Main Business and Products
(4) Enterprise Retail Networks and Suppliers
(5) Analysis of Enterprise Operational Situation
(6) Analysis of Enterprise Advantages and Disadvantages
(7) Analysis of Enterprise Investment Development Trend
Chapter 4: Market Status and Prospects Analysis of Pharmaceutical Wholesale Market
4.1 Operational Status and Prospects Analysis of Pharmaceutical Wholesale Market
4.1.1 Functional Analysis of Pharmaceutical Wholesale Enterprises
(1) Logistics Function
(2) Sales Function
(3) Finance Function
(4) Information Function
(5) Change Trend of Functions
4.1.2 Analysis of USA Pharmaceutical Wholesale Enterprises
(1) USA Drug Supply Chain
(2) Operational Environment of USA Pharmaceutical Wholesale Enterprises
(3) Operational Features of USA Pharmaceutical Wholesale Enterprises
(4) Analysis of McKesson, USA
4.1.3 Analysis of Japan Pharmaceutical Wholesale Enterprises
(1) USA Drug Supply Chain
(2) Operational Environment of Japan Pharmaceutical Wholesale Enterprises
(3) Operational Features of Japan Pharmaceutical Wholesale Enterprises
(4) Analysis of Toho Pharmaceutical Co., Ltd.
4.2 Domestic Pharmaceutical Wholesale Modes and Market Status
4.2.1 Analysis of Pharmaceutical Wholesale Modes
(1) Pure Sales and Distribution
(2) Fast Wholesales
4.2.2 Analysis of Pharmaceutical Wholesale Market Size
(1) Enterprise Quantity Size
(2) Enterprise Sales Volume
4.2.3 Profit Analysis of Pharmaceutical Wholesale Market
4.2.4 Analysis of Types of Pharmaceutical Wholesale Enterprises
4.2.5 Concentration Analysis of Pharmaceutical Wholesale Market
4.3 Development Strategies for Small-and-medium sized Pharmaceutical Wholesale Enterprises
4.3.1 Competition Environment of Small-and-medium sized Pharmaceutical Wholesale Enterprises
(1) Bargaining Power of Suppliers
(2) Bargaining Power of Buyers
(3) Threats of New Entrants
(4) Threats of Substitutes
(5) Threats of Current Competitors in Industry
4.3.2 Advantages and Disadvantages Analysis of Small-and-medium sized Pharmaceutical Wholesale Enterprises
(1) Advantages of Small-and-medium sized Pharmaceutical Wholesale Enterprises
(2) Disadvantages Analysis of Small-and-medium sized Pharmaceutical Wholesale Enterprises
4.3.3 Major Problems in Advantages and Disadvantages Analysis of Small-and-medium sized Pharmaceutical Wholesale Enterprises
(1) Product Problems
(2) Sales Problems
(3) Information Problems
(4) Talent Problems
4.3.4 Development Strategies for Small-and-medium sized Pharmaceutical Wholesale Enterprises
(1) Product Strategies
(2) Sales Strategies
(3) Information Strategies
(4) Talent Strategies
4.4 Development Prospects Analysis of Pharmaceutical Wholesale Market
4.4.1 Development Opportunities of Pharmaceutical Wholesale Enterprises
4.4.2 Development Risks of Pharmaceutical Wholesale Enterprises
4.4.3 Development Prospects for Pharmaceutical Wholesale Enterprises
Chapter 5: Pharmaceutical Logistics Market Status and Business Modes
5.1 Domestic Pharmaceutical Logistics Market Status and Prospects
5.1.1 Function and Classification of Pharmaceutical Logistics
(1) Definition of Pharmaceutical Logistics
(2) Functions of Pharmaceutical Logistics
(3) Classification of Pharmaceutical Logistics
5.1.2 Influencing Factors to Development of Pharmaceutical Logistics
(1) Geographic Factor
(2) Economic Factor
(3) Scientific Factor
(4) Management System Factor
(5) Comprehensive Anthropogenic Factor
5.1.3 Development Status of Pharmaceutical Logistics Market
5.1.4 Operational Features of Pharmaceutical Logistics Market
5.1.5 Logistic Cost of Pharmaceutical Logistics Enterprises
5.1.6 Demand Size of Pharmaceutical Logistics Market
5.1.7 Competition Trend of Pharmaceutical Logistics Market
5.1.8 Construction Status of Pharmaceutical Logistics Projects
5.1.9 Development Forecast for Pharmaceutical Logistics Market
5.2 Operational Modes and Features of International Pharmaceutical Logistics Market
5.2.1 Operational Modes and Features of USA Pharmaceutical Logistics Market
(1) Analysis of Related Policies of USA Logistics Industry
(2) Market Environment of USA Pharmaceutical Logistics Industry
(3) Enterprise Types of USA Pharmaceutical Logistics Industry
(4) Operational Modes of USA Pharmaceutical Logistics Industry
(5) Development Features of USA Pharmaceutical Logistics Industry
5.2.2 Operational Modes and Features of Japan Pharmaceutical Logistics Market
(1) Analysis of Related Policies of Japan Logistics Industry
(2) Market Environment of Japan Pharmaceutical Logistics Industry
(3) Operational Modes of Japan Pharmaceutical Logistics Industry
(4) Development Features of Japan Pharmaceutical Logistics Industry
5.2.3 Operational Modes and Features of EU Pharmaceutical Logistics Market
(1) Analysis of Related Policies of EU Logistics Industry
(2) Market Environment of EU Pharmaceutical Logistics Industry
(3) Operational Modes of EU Pharmaceutical Logistics Industry
(4) Development Features of EU Pharmaceutical Logistics Industry
5.2.4 Development Experiential Learning of International Pharmaceutical Logistics Industry
(1) Unity of Supply Chain Management
(2) Solution Plan to Provide Information
(3) Complete Logistics Distribution Network
(4) Extensive Application of Encoding Technologies
(5) Simple and Practical Information Platform Operation
5.3 Cases Explanation of Pharmaceutical Logistics Business Mode
5.3.1 Overall Features of Pharmaceutical Logistics Business Mode
5.3.2 Development Formats of Pharmaceutical Logistics Business Mode
5.3.3 Explanation of Major Pharmaceutical Logistics Business Modes
(1) Jointown Mode
(2) Taihe Mode
(3) Bangda Mode
(4) Beijing Medical Group Mode
5.3.4 SWOT Analysis of Pharmaceutical Logistics Business Modes
(1) Advantages
(2) Disadvantages
(3) Opportunities
(4) Threats
5.4 Operational Methods and Features of Market Segmentation of Pharmaceutical Logistics
5.4.1 Commercial Distribution-oriented Pharmaceutical Logistics Market
(1) Market Environment of Commercial Distribution Pharmaceutical Logistics Market
(2) Operational Methods of Commercial Distribution Pharmaceutical Logistics Market
(3) Mode Features of Commercial Distribution Pharmaceutical Logistics Market
(4) Influencing Factors of Commercial Distribution Pharmaceutical Logistics Market
(5) Comparison Analysis of Similar Foreign Modes
5.4.2 Retail Chain-oriented Pharmaceutical Logistics Market
(1) Market Environment of Retail Chain Pharmaceutical Logistics Market
(2) Operational Methods of Retail Chain Pharmaceutical Logistics Market
(3) Mode Features of Retail Chain Pharmaceutical Logistics Market
(4) Influencing Factors of Retail Chain Pharmaceutical Logistics Market
(5) Comparison Analysis of Similar Foreign Modes
5.4.3 Third-party Logistics-oriented Pharmaceutical Logistics Market
(1) Market Environment of Third-party Logistics Pharmaceutical Logistics Market
(2) Operational Methods of Third-party Logistics Pharmaceutical Logistics Market
(3) Mode Features of Third-party Logistics Pharmaceutical Logistics Market
(4) Influencing Factors of Third-party Logistics Pharmaceutical Logistics Market
(5) Comparison Analysis of Similar Foreign Modes
The most distinctive characteristics of this report is forward-looking and timeliness. Through analyzing forward-looking characteristic of abundant first-hand market data, we deeply and objectively dissect China pharmaceutical busines’s overall market capacity, market size, competitive landscape and characteristics of market demand. Furthermore, based on future development tracks and years' practice experience of pharmaceutical business, we conduct prudent analysis and forecast for pharmaceutical businesy's future development trend.
Benefit from urbanization, aged tendency of population and medical consumption market growth due to the spread of national healthcare system, China pharmaceutical circulation market develops extremely fast during these years. According to statistics, China pharmaceutical market size increased from 170.5 billion Yuan in 2001 to 653.6 billion Yuan in 2010, with a compound growth rate of 16.1%; the retail terminal market has maintained an increasing trend for ten years, which grew from 34.3 billion Yuan to 172.4 billion Yuan, with a compound growth rate of 19.6% over the same period. Driven by the policies and the development of the up and down stream industries, China pharmaceutical circulation market will continue to grow steadily in the future.
With the gradual expansion of pharmaceutical business market, the competition among pharmaceutical business enterprises becomes fiercer and fiercer. In recent years, China National Pharmaceutical Group Corporation, Shanghai Pharmaceutical (Group) Co., Ltd., as well as Jointown Pharmaceutical Group Co., Ltd. always keep the top 3 in pharmaceutical business field. Meanwhile, the market concentration of pharmaceutical business keeps increasing, but the China’s market concentration still has a relatively large improving space compared with some developed countries, such as USA and Japan. Due to the growing competition, pharmaceutical business giants begin to accelerate the layout and carry out more acquisition and merger activities. Promoted by new healthcare reform, the reorganization and integration of pharmaceutical business speed up and the concentration of pharmaceutical business market is expected to further enhance.
The report mainly analyzes the policy environment and demand environment of China pharmaceutical business development; the development status and development prospect of pharmaceutical business; the competition condition of pharmaceutical business enterprises and development situation of competitive rivals; the development situation of pharmaceutical wholesales market; the development situation of pharmaceutical logistics market; the development situation of pharmaceutical business terminals, as well as the development situation of pharmaceutical business in key cities. Meanwhile, with comprehensive and specific first-hand market data over the past 5 years, Forward helps you to grasp the market and development trends of pharmaceutical business market, so as to win advantages from competition!
The most distinctive characteristics of this report is forward-looking and timeliness. Through analyzing forward-looking characteristic of abundant first-hand market data, we deeply and objectively dissect China pharmaceutical busines’s overall market capacity, market size, competitive landscape and characteristics of market demand. Furthermore, based on future development tracks and years' practice experience of pharmaceutical business, we conduct prudent analysis and forecast for pharmaceutical businesy's future development trend. This report helps pharmaceutical wholesales enterprises, pharmaceutical retailing enterprises, pharmaceutical logistics enterprises and investment enterprises to precisely grasp current latest developments of the market. Afterwards, they can make wise operating decisions and define enterprises' development directions.
Here, we would like to express our sincere gratitude to State Information Center, Bureau of Statistics of China, International Information Research Institute, Chinese Academy of International Trade and Economic Cooperation, Tsinghua University Library, Development Research Center of the State Council and Beijing Essence Forward Research Center, for their great support when we conduct this report!
Notice: All the market data, especially corporations' ranking data in the report, only for business reference. Please do not take the data for enterprise publicity. Thank you! Or Forward shall not take any responsibility for any consequences!
Qianzhan Business Information Co., Ltd. Industry Research Center
Research Team of Pharmaceutical Business
The National Bureau of Statistics Foreign-related investigation Permission
National Innovation Company and Dual Software Certified Enterprise
The only DRC desginated Enterprise of the Industry Yearbook
National Ministry of Commerce designated Industrial Early Warning and Monitoring Workstation
Guangdong Province Enterprise of Observing Contract and Valuing Credit
Qianzhan is an industry consulting service provider with national innovation company qualification, independent research and development of industrial big data and Dual Software Certification.
Qianzhan is a consulting and research organization that has been engaged in business consulting for over 16 years in China.
Qianzhan is a consulting service provider with a team of nearly 300 industrial researchers and analysts.
Qianzhan is a consulting service provider with an in-house expert pool of 1200 experts.
Qianzhan is a research and consulting organization that have served 180000 clients and received over positive comments from 100000 of our clients.
Qianzhan is an industry research and consulting organization that has been designated by the highest authority, the DRC, to prepare the yearbook.
Qianzhan is an industry planning and consulting organization that adopts the internationally synchronized SCP scientific analysis model and the perfect industry chain research map to guide the business planning and consulting.
Qizhan is a consulting service organization that helps enterprises to solve the five aspects of industry research, planning, strategic design, capital operation and implementation.
Free Hotline：+86 400-068-7188
Customer Hotline：+86 755 - 82925195 / 82925295
Email Address：service@qianzhan.com
3rd Floor, FIYTA Building West, High Tech South Avenue 1, Nanshan District, Shenzhen, China
Location：Rm.1106, Building 1, Jiayu International Plaza, Songhu Road, Yangpu District,
Shanghai, China
Quality Assured
Offer a forward-looking vision to all of our customers.
Customer Service
We welcome any feedbacks and suggestions to make our customers 100% satisfied.
Qualification Certificates
Having more than 20 qualification certificates, including Innovation Company Certificate and Foreign-related investigation Permission etc.
Customers Testimonials
Thank you for recognizing our high quality products and professional, rigorous and sincere service.
